摘要
再生医学领域研究工作近年来不断深入,目前诱导多能干细胞具有的多组织潜能在药物研发中的应用价值也被不断挖掘出来。基于多能干细胞药物研发技术现状,文章首先分析了多能干细胞产生技术的主要技术内容,其次对药物研发方面诱导多能干细胞的应用途径与模式进行了阐述和分析,希望可以为多能干细胞在药物研发方面治疗与应用提供更为丰富的经济价值与应用价值。
In recent years, the research work in the field of regenerative medicine has continued to deepen. At present, the application value of multi-organizational potential in induced pluripotent stem cells in drug research and development has also been explored. Based on the current situation of pluripotent stem cell drug research and development technology, this paper first analyzes the main technical content of pluripotent stem cell production technology, and then expounds and analyzes the application ways and modes of inducing pluripotent stem cells in drug research and development, hoping to provide more economic value and application value for the treatment and application of pluripotent stem cells in drug research and development.
引文
[1]吴升星,李艳,张海燕,刘洋,赖琼,杨明.诱导多能干细胞技术在药物研发领域中的前景[J].中国生物工程杂志,2017,37(11):116-122.
[2]安世民,丁旭苹,朱亮.基于诱导多能干细胞的高内涵筛选平台在药物研发中的应用[J].中国新药杂志,2015,24(02):171-176.
[3]赵增明,方海琴,何俊,武瑞琴,彭双清.胚胎干细胞毒性评价模型的建立及其在药物安全性评价中的应用[J].中国药理学与毒理学杂志,2013,27(03):487-488.
[4]王雪莲,杨树龙,黄家学.诱导多能干细胞制备技术及其在药物研发中的应用[J].生物医学工程与临床,2011,15(06):596-598.